HWM
AZN icon

Heirloom Wealth Management’s AstraZeneca AZN Stock Holding History

Heirloom Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35,754
Closed -$5.12M – 53
2023
Q2 		$5.12M Buy
35,754
+1,175
+3% +$173K 2.22% 18
2023
Q1 		$4.8M Buy
34,579
+10,414
+43% +$1.4M 2.29% 17
2022
Q4 		$3.28M Buy
+24,165
New +$3.03M 2.04% 19
2022
Q2 		$4.3M Buy
32,613
+2,883
+10% +$378K 3.52% 13
2022
Q1 		$3.75M Buy
+29,730
New +$3.57M 2.61% 15

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Heirloom Wealth Management's AZN Position: Q3 2023 in Review

Heirloom Wealth Management sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 35,754 shares — an estimated $5.12M sold.

Heirloom Wealth Management first reported a position in AZN in Q1 2022 and held it in 5 quarters. The position peaked at $5.12M in Q2 2023. 1,075 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • Heirloom Wealth Management reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
  • Heirloom Wealth Management sold 35,754 AstraZeneca shares in Q3 2023, an estimated $5.12M.
  • Heirloom Wealth Management first reported a position in AstraZeneca in Q1 2022 and held it in 5 quarters.
  • Heirloom Wealth Management's AstraZeneca position peaked at $5.12M in Q2 2023.
  • 1,075 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Heirloom Wealth Management's 13F filing for Q3 2023, filed 23 Oct 2023.